Similar documents

CHEMOTHERAPY Proteus mirabilis GN-79 Escherichia coli No. 35 Proteus vulgaris GN-76 Pseudomonas aeruginosa No. 11 Escherichia coli ML-1410 RGN-823 Kle



CHEMOTHERAPY DEC Table 1 Antibacterial spectra of T-1982, CTT, CMZ, CTX, CPZ and CEZ 106 CFU/ml Note: P; Peptococcus, S; Streptococcus, G; Gaffk

Fig. 1 Chemical structure of DL-8280

CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates

CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels of mezlocillin

VOL. 34 S-2 CHEMOTH8RAPY 913

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study

VOL.35 S-2 CHEMOTHERAPY Table 1 Sex and age distribution Table 2 Applications of treatment with carumonam Table 3 Concentration of carumonam in human

CHEMOTHERAPY JUN Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter cloacae 27, Proteus rettgeri 7, Proteus inconstans 20, Proteus

CHEMOTHERAPY FEB Table 1 Background of volunteers

Fig. 1 Chemical structure of KW-1070


CHEMOTHERAPY


CHEMOTHERAPY JUNE 1986

Table1MIC of BAY o 9867 against standard strains

CHEMOTHERAPY Fig. 1 Chemical structure of CXM-AX

CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin

988 CHEMOTHERAPY NOV. 1971


Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad


VOL.42 S-1



Table 1. Antibacterial spectrum SBT ABPC ABPC CPZ : sulbactamiampicillin : ampicillin : cefoperazone

Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.


Key words: Antibiotics, Intestinal bacterial flora, Germfree mouse

Clostridium difficile ciprofloxacin, ofloxacin, norfloxacin Bifidobacterium Lactobacillus Lactobacillus Bacteroides fragilis B. fragilis C. difficile

epidermidis, Enterococcus faecalis, Enterococcus Klebsiella pneumoniae, Proteus mirabilis, indolepositive Proteus spp., Enterobacter spp., Serratia

VOL. 43 NO. 4

Title 泌尿器科領域に於ける17-Ketosteroidの研究 17-Ketosteroidの臨床的研究 第 III 篇 : 尿 Author(s) 卜部, 敏入 Citation 泌尿器科紀要 (1958), 4(1): 3-31 Issue Date URL

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST



CHEMOTHERAPY JUNE 1987 Table1 Media used *BHIB, brain heart infusion broth (Difco); /3 -NAD, S -nicotinamidoadeninedinucleotide (Sigma Chemical Co.);

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec LVFX 100 mg 3 / mg 2 / LVFX PK PD mg mg 1 1 AUC/MIC


(ABPC), Carbenicillin (CBPC), Surbenicillin (SBPC), Piperacillin (PIPC), Cephalexin (CEX), Cefaclor (CCL), Cephalothin (CET), Cefazolin (CEZ), Cefotia

Jan THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis


Fig.2. Sensitivity distribution of clinical isolates of S. epidermidis (24 strains, 106 CFU/ml) Staphylococcus aureus Staphylococcus epider- midis Ent





The Japanese Journal of Psychology 1974, Vol. 44, No. 6, AN ANALYSIS OF WORD ATTRIBUTES IMAGERY, CONCRETENESS, MEANINGFULNESS AND EASE OF LEAR

CHEMOTHERAPY MAY. 1988

A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc

Hisao Takayasu Department of Urology, Faculty of Medicine, University of Tokyo Masaaki Ohkoshi Department of Urology, Tokai University School of Medic

Table 1 Characteristics of the study participants in Imari municipal hospital

VOL.39 S-3

VOL. 36 S-3 CHEMOTHERAPY 437

Endocrinological and statistical analysis of ovarian function in hysterectomized patients Masaya HAYAFUJI, Kazuaki KATAYAMA and Matsuto MOCHIZUKI Depa

Visual Evaluation of Polka-dot Patterns Yoojin LEE and Nobuko NARUSE * Granduate School of Bunka Women's University, and * Faculty of Fashion Science,


2108 CHEMOTHERAPY SEPT Table 1 Antimicrobial spectrum Fig. 1



Postoperative Assessment by Using a Torque Machine (BIODEX) and MRIs in Patients treated for a Recurrent Anterior Dislocation or Subluxation of the Sh

The Journal of the Japan Academy of Nursing Administration and Policies Vol 7, No 2, pp 19 _ 30, 2004 Survey on Counseling Services Performed by Nursi

) 5 Lawton QOL 4 4 QOL Lawton 4) Philadelphia Geriatric Center Affect Rating ScaleARS ARS QOL 5) HDS R

Ⅱ. 用語の操作的定義 Ⅲ. 対象と方法 1. 対象 WAM NET 2. 調査期間 : 3. 調査方法 4. 調査内容 5. 分析方法 FisherMann-Whitney U Kruskal-Wallis SPSS. for Windows 6. 倫理的配慮 Vol. No.

Title 外傷性脊髄損傷患者の泌尿器科学的研究第 3 報 : 上部尿路のレ線学的研究並びに腎機能について Author(s) 伊藤, 順勉 Citation 泌尿器科紀要 (1965), 11(4): Issue Date URL


Transcription:

CHEMOTHERAPY AUG. 1982

VOL. 30 NO. 8 CHEMOTHERAPY Fig.1 Relation between various-closis of cefazolin and detection rate of organisms in heart blood of dying mice with E. coli and P. aeruginosa infection Fig. 2 Relation between various dosis of cefmetazole and detection rate of organisms in heart blood of dying mice with E. coli and P. aeruginosa infection

866 CHEMOTHERAPY AUG. 1992 Fig. 3 RvIiition between vartotiti closis of cefotaxime and detection rate of organisms in livart blood (of dying mice with E. coli and P. aeruginosa infection Fig. 4 Relation b( tween various dosis of cefoperazone and detection rate of organisms in heart blood of dying mice with E. coli and P. aeruginosa infection

VOL. 30 NO. 8 CHEMOTHERAPY 867 Fig. 5 Relation between various dosis of cefsulodin and detection rate of organisms in heart blood of dying mice with E. coli and P. aeruginosa infection Fig. 6 Relation between various dosis of latamoxef and detection rate of organisms in heart blood of dying mice with E. coli and P. aeruginosa infection

868 CHEMOTHERAPY AUG. 1982 Fig. 7 Serum levels of various antibiotics in normal mice Fig. 8 Serum levels of Latamoxef and cefazolin in experimental mice mixed infection with E. coli C-11 and P. aeruginosa E-7 hfucin (+) Fig. 9 Serum levels of Latamoxef and cefazolia in experimental mice mixed infection with E. coli C-11 and P. aeruginosa E-7 mocm. (-) Administration:1 hr. after the infection Administration: 1 hr. after the infectios

VOL. 30 NO. 8 CHEMOTHERAPY 5) BODEY, G. P.; B. A. NIES & E. J. FREIREICH: 3) HOCHSTEIN, H. D.; W. R. KIRKHAM & V. M. YOUNG: Recovery of more than 1 organism in septicemias. New Eng. J. Med. 273 (9): 468 `474, 1964 4) HERMANS, P. E.; F. A. C. P. & J. A. WASHING- TON: Polymicrobial bacteremia. Ann. Int. Med. 73 : 387 `392, 1970 Multiple organism septicemia in acute leukemia analysis of 54 septicemia. Arch. Intern. Med. 116: 266 `272, 1965 10) MCCABE, W. R. & G. G. JACKSON: Gram-negative bacteremia I. Etiology and ecology. Arch. Int. Med. 110: 847 `855, 1962 11) HODGIN, U. G. & J. P. SANFORD: Gram-nagative rod bacteremia: An analysis of 100 patients. Am. J. Med. 39: 952 `960, 1965 12) DUPONT, H. L. & W. W. SPINK : Infections due to gram-negative organisms: An analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958 `1966. Medicine 48: 307-432, 1969 13) BRYANT, R. E.; A. F. HOOD, C. E. HOOD & M. G. KOENIG: Factors affecting mortality of gramnegative rod bacteremia. Arch. Intern. Med. 127: 120 `128, 1971 therapy 22(6) : 1099 `1107, 1974 15) LEWIS, J. & F. R. J. FEKETY: Gram-negative bacteremia. Johnes Hopkins Med. J. 124 (Feb.): 106 `111, 1968 16) WEIL, M. H.; H. SHUBIN & M. BIDDLE: Shock caused by gram-negative microorganisms:

CHEMO THER APY PROTECTING EFFECTS OF VARIOUS CEPHALOSPORINS AGAINST EXPERIMENTAL MICE MIXED INFECTION WITH E. COLI AND P. AERUGINOSA ISAMU YOSHIDA, MASATOSHI OGAWA, SHUICHI MIYAZAKI, YASUKO KANEKO and SACHIKO GOTO Department of Microbiology, Toho University School of Medicine Protecting effects of cephalosporins (cefazolin, cefotaxime, cefoperazone and cefsulodin), cephamycin (cefmetazole) and oxacephem (latamoxef) against experimental mice mixed infection with E. coli and P. aeruginosa were investigated and the results were taken as follows: 1) ED50 values of all antibiotics to the mixed infection were larger than to the single infection with the equal dose. Protecting effects of all antibiotics fell. To the single infection with E. coli in a dose above MLD, small ED50 followed cefotaxime, latamoxef, cefoperazone, cefazolin, cefmetazole and cefsulodin in order and with P. aeruginosa, followed cefsulodin, latamoxef and cefoperazone. To the mixed infection, latamoxef was the most effective among the test antibiotics and the efficacy of cefsulodin and cefoperazone followed that of latamoxef in that order in small dose. 2) From the heart blood of each dead mouse after antibiotics administration, cefsulodin administered groups were cultivated E. coli, whereas on other antibiotics, large dose administered groups were cultivated P. aeruginosa and small dose administered groups were cultivated P. aeruginosa and E. coli. 3) Serum levels of normal mice were cefazolin, latamoxef, cefmetazole, cefotaxime, cefoperazone and cefsulodin in order of height. But at the mixed infectious mice latamoxef was higher serum level than cefazolin.